JP2005505605A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005505605A5 JP2005505605A5 JP2003535798A JP2003535798A JP2005505605A5 JP 2005505605 A5 JP2005505605 A5 JP 2005505605A5 JP 2003535798 A JP2003535798 A JP 2003535798A JP 2003535798 A JP2003535798 A JP 2003535798A JP 2005505605 A5 JP2005505605 A5 JP 2005505605A5
- Authority
- JP
- Japan
- Prior art keywords
- rosuvastatin
- medicament
- patient
- risk
- dementia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012289 Dementia Diseases 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 claims 2
- 229960000672 rosuvastatin Drugs 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0103509A SE0103509D0 (sv) | 2001-10-19 | 2001-10-19 | Rosuvastatin in pre demented states |
| PCT/SE2002/001911 WO2003032995A1 (en) | 2001-10-19 | 2002-10-18 | Rosuvastatin in pre demented states |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005505605A JP2005505605A (ja) | 2005-02-24 |
| JP2005505605A5 true JP2005505605A5 (enExample) | 2006-01-05 |
Family
ID=20285721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003535798A Pending JP2005505605A (ja) | 2001-10-19 | 2002-10-18 | 前痴呆状態におけるロスバスタチン |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20060229321A1 (enExample) |
| EP (1) | EP1446123A1 (enExample) |
| JP (1) | JP2005505605A (enExample) |
| KR (1) | KR20040058201A (enExample) |
| CN (1) | CN1604780A (enExample) |
| AR (1) | AR036891A1 (enExample) |
| BR (1) | BR0213434A (enExample) |
| CA (1) | CA2463597A1 (enExample) |
| CO (1) | CO5580773A2 (enExample) |
| HU (1) | HUP0401798A3 (enExample) |
| IL (1) | IL161380A0 (enExample) |
| IS (1) | IS7218A (enExample) |
| MX (1) | MXPA04003631A (enExample) |
| NO (1) | NO20041840L (enExample) |
| PL (1) | PL369573A1 (enExample) |
| RU (1) | RU2004112422A (enExample) |
| SE (1) | SE0103509D0 (enExample) |
| WO (1) | WO2003032995A1 (enExample) |
| ZA (1) | ZA200402844B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7396927B2 (en) | 2003-08-28 | 2008-07-08 | Teva Pharmaceutical Industries Ltd. | Process for preparation of rosuvastatin calcium |
| GB0322552D0 (en) | 2003-09-26 | 2003-10-29 | Astrazeneca Uk Ltd | Therapeutic treatment |
| WO2005051921A1 (en) | 2003-11-24 | 2005-06-09 | Teva Pharmaceutical Industries Ltd. | Crystalline ammonium salts of rosuvastatin |
| US7244844B2 (en) | 2003-12-02 | 2007-07-17 | Teva Pharmaceutical Industries Ltd. | Reference standard for characterization of rosuvastatin |
| JP2007508379A (ja) | 2004-07-13 | 2007-04-05 | テバ ファーマシューティカル インダストリーズ リミティド | Ｔｅｍｐｏ媒介型酸化段階を包含するロスバスタチンの調製方法 |
| CA2680693A1 (en) | 2005-02-22 | 2006-08-31 | Teva Pharmaceutical Industries Ltd. | Preparation of rosuvastatin |
| MX2007004427A (es) | 2005-08-16 | 2007-06-14 | Teva Pharma | Intermedio de rosuvastatina cristalina. |
| WO2012073256A1 (en) | 2010-11-29 | 2012-06-07 | Cadila Healthcare Limited | Salts of rosuvastatin |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2648897B2 (ja) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
| US7189703B2 (en) * | 1998-01-09 | 2007-03-13 | Intracell, Llc | Treatment and diagnosis of alzheimer's disease |
| AR022462A1 (es) * | 1999-02-06 | 2002-09-04 | Astrazeneca Uk Ltd | Uso de un agente que disminuye el colesterol |
| US20030100493A1 (en) * | 2001-07-19 | 2003-05-29 | Sol Weiss | Sublingual use of inhibitors in the biosynthesis of cholesterol |
-
2001
- 2001-10-19 SE SE0103509A patent/SE0103509D0/xx unknown
-
2002
- 2002-10-17 AR ARP020103895A patent/AR036891A1/es not_active Application Discontinuation
- 2002-10-18 JP JP2003535798A patent/JP2005505605A/ja active Pending
- 2002-10-18 RU RU2004112422/14A patent/RU2004112422A/ru not_active Application Discontinuation
- 2002-10-18 CA CA002463597A patent/CA2463597A1/en not_active Abandoned
- 2002-10-18 MX MXPA04003631A patent/MXPA04003631A/es not_active Application Discontinuation
- 2002-10-18 KR KR10-2004-7005585A patent/KR20040058201A/ko not_active Withdrawn
- 2002-10-18 HU HU0401798A patent/HUP0401798A3/hu unknown
- 2002-10-18 IL IL16138002A patent/IL161380A0/xx unknown
- 2002-10-18 WO PCT/SE2002/001911 patent/WO2003032995A1/en not_active Ceased
- 2002-10-18 CN CNA028253477A patent/CN1604780A/zh active Pending
- 2002-10-18 PL PL02369573A patent/PL369573A1/xx not_active Application Discontinuation
- 2002-10-18 BR BR0213434-9A patent/BR0213434A/pt not_active Application Discontinuation
- 2002-10-18 US US10/492,971 patent/US20060229321A1/en not_active Abandoned
- 2002-10-18 EP EP02783893A patent/EP1446123A1/en not_active Withdrawn
-
2004
- 2004-04-13 IS IS7218A patent/IS7218A/is unknown
- 2004-04-15 ZA ZA200402844A patent/ZA200402844B/en unknown
- 2004-04-19 CO CO04035705A patent/CO5580773A2/es not_active Application Discontinuation
- 2004-05-05 NO NO20041840A patent/NO20041840L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2016026I1 (no) | Kombinasjon av rilpivirine eller en terapeutisk ekvivalent form derav så som et farmasøytisk akseptabelt salt av rilpivirine innbefattende hydrokloridsaltet av rilpivirine samt emtricitabine samt tenofovir alafenamid eller et farmasøytisk akseptabelt salt derav, spesielt tenofovir alafenamid fumarat | |
| ME02688B (me) | Hinazolinoni kao inhibitori humane fosfatidilinozitol 3 - kinaze delta | |
| ZA200802897B (en) | New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of Alzheimer's Disease | |
| JP2005500357A5 (enExample) | ||
| EA200301165A1 (ru) | Лекарственное средство на основе оксикодона | |
| DE60030844D1 (de) | Kombinationen von formoterol und tiotropium-salz | |
| IL205262A (en) | Use of Risderdone Acid or its Pharmaceutical Salt to produce oral medication once a month for the prevention and treatment of osteoporosis | |
| EP1635762A4 (en) | LOW-DOSED PHARMACEUTICAL POWDER FOR INHALATION | |
| BR0015908A (pt) | Emprego de compostos org nicos no tratamento de doenças | |
| GEP20074208B (en) | Substituted amides active at the cannabinoid-1 receptor | |
| DE50212546D1 (de) | Orale darreichungsformen für propiverin oder seinen pharmazeutisch annehmbaren salzen mit verlängerter wirkstofffreisetzung | |
| AU2003259381A8 (en) | Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases | |
| EP1558214A4 (en) | MICROEMULSION CONCENTRATES FOR THE ORAL ADMINISTRATION OF WATER-INSOLICED MEDICAMENT AGAINST COLLECTIONS AND METHOD OF PREPARATION THEREOF | |
| DE50005529D1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
| DK1383752T3 (da) | Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser | |
| RU2004135563A (ru) | Лекарственное средство для лечения повышенной активности мочевого пузыря | |
| JP2008513510A5 (enExample) | ||
| JP2005508963A5 (enExample) | ||
| JP2005505605A5 (enExample) | ||
| RU2004112422A (ru) | Роувастатин в преддеменционных состояниях | |
| EA200701181A1 (ru) | Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний | |
| CA2496476A1 (en) | Therapeutic use | |
| NO20043483L (no) | Anvendelse av melagatran for fremstilling av et medikament for behandling av type 1 Diabetes mellitus | |
| BR0009080A (pt) | Método de tratamento da apnéia do sono | |
| FR2848817B1 (fr) | Matelas therapeutique tricouches pour patients obeses |